XM does not provide services to residents of the United States of America.

UK Stocks-Factors to watch on July 25



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-UK Stocks-Factors to watch on July 25</title></head><body>

Adds new items, updates futures

July 25 (Reuters) -Britain's FTSE 100 .FTSE index is seen opening lower on Thursday, with futures FFIc1 down 0.6%.


* ASTRAZENECA: Anglo-Swedish drugmaker AstraZeneca AZN.L raised its sales and profit forecasts for 2024 and topped analyst expectations for second-quarter revenue, buoyed by demand for its therapies for cancer and rare diseases.

* UNILEVER: Unilever ULVR.L reported worse-than-expected underlying quarterly sales after it was unable to win back shoppers it had alienated in recent years with higher prices.

* LLOYDS: Lloyds Banking Group LLOY.L reported a 14% fall in first-half pretax profit to 3.3 billion pounds ($4.25 billion), broadly in line with forecasts.

* VODAFONE: Vodafone VOD.L reported a 5.4% rise in service revenue in the first quarter, a slowdown on the previous three quarters, after its biggest market Germany went into reverse due to changes in cable TV regulation.

* ANGLO AMERICAN: Anglo American AAL.L took a further $1.6 billion writedown at its costly fertiliser project in Britain as it takes more steps to cut costs after making a loss of $672 million in the first half.

* BT: Britain's BT BT.L said it was on track to deliver its financial outlook for the year, with its boss adding there was more to do to simplify the company.

* British American Tobacco: British American Tobacco BATS.L reported a 1.3% rise in half-year profit, exceeding analyst expectations.

* ITV: Britain's ITV ITV.L reported a 10% rise in total advertising revenue in its first half.

* CENTRICA: British Gas owner Centrica CNA.L reported a fall in first-half adjusted operating profit.

* REVOLUT: British fintech Revolut said it had received a UK banking licence with restrictions from the Prudential Regulation Authority.


* For more on the factors affecting European stocks, please click on: LIVE/

TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB



($1 = 0.7760 pounds)



Reporting by Prerna Bedi and DhanushVignesh Babu in Bengaluru

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.